Is Prosogan Safe in Breastfeeding

I am a breastfeeding mother and i want to know if it is safe to use Prosogan? Is Prosogan safe for nursing mother and child? Does Prosogan extracts into breast milk? Does Prosogan has any long term or short term side effects on infants? Can Prosogan influence milk supply or can Prosogan decrease milk supply in lactating mothers?

At latest update, relevant information on excretion into breast milk was not found. Due to a high serum-protein-binding capacity, excretion of Prosogan into breast milk is non-significant. Since it's neutralized by the acid pH of stomach, capsules with enteric coated granules are used. Because of this, it is thought that the small quantity of Prosogan that may reach the breast milk would be neutralized by infant's stomach. In addition, absorption is greatly decreased by the presence of food. Both Omeprazole and Pantoprazole pertain to the same chemical group with similar pharmacokinetics that are excreted in non-significant amount into the breast milk. Medication that has been used for treatment of newborn and premature infants. Hyperprolactinemia and galactorrhea have been reported by the use of such medication, though some authors have failed to show the same findings.

No information is available on the use of Prosogan during breastfeeding. However, Prosogan has been used safely in newborn infants, so it is unlikely that the amount in breastmilk would be harmful.

The Spanish pharmacovigilance system found 3 cases of gynecomastia associated with Prosogan reported during the time period of 1982 to 2006.[1] One case of elevated serum prolactin and galactorrhea was reported in a 21-year-old man. When omeprazole was substituted for Prosogan, the serum prolactin decreased to the normal range and galactorrhea ceased. Although this case occurred in Spain, it was not included in the report above.[2] A 13-year-old girl with a recent history of bilateral galactorrhea and hyperprolactinemia from omeprazole and domperidone on separate occasions was given Prosogan to prevent gastrointestinal irritation following intravenous diclofenac for a severe headache. After 3 days of Prosogan therapy, she again developed galactorrhea and an elevated serum prolactin that returned to normal a week after discontinuing Prosogan.[3] A 17-year-old woman using a progestin-containing IUD for 1 year began Prosogan 15 mg daily and presented after 1 week with bilateral galactorrhea and hyperprolactinemia of 92 mcg/L. Seventy-two hours after discontinuation of Prosogan, galactorrhea ceased. Four months later, serum prolactin was normal at 24.1 mcg/L with no recurrence of galactorrhea. The authors judged the adverse reaction likely to be caused by Prosogan.[4] The prolactin level in a mother with established lactation may not affect her ability to breastfeed.